CVS Health and UnitedHealth Group have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.

The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" against pharmacy benefit managers.

UnitedHealth Group, CVS Health and Cigna all submitted motions Oct. 8 to remove Lina Khan from the Federal Trade Commission’s ongoing antitrust lawsuit. | UnitedHealth, CVS Health and Cigna all view FTC chair Lina Khan as unfair toward PBMs and say she should be removed from the FTC's recently filed antitrust lawsuit.